June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Retinal proteome changes following experimental branch retinal vein occlusion and intervention with intravitreal dexamethasone implants
Author Affiliations & Notes
  • Lasse Joergensen Cehofski
    Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark
    Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
  • Alexander Nørgård Alsing
    Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
    Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark
  • Anders Kruse
    Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark
  • Sigridur Olga Magnusdottir
    Biomedical Research Laboratory, Aalborg University Hospital, Aalborg, Denmark
  • Bent Honoré
    Department of Biomedicine, Aarhus University, Aarhus, Denmark
  • Henrik Vorum
    Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
    Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark
  • Footnotes
    Commercial Relationships   Lasse Cehofski, None; Alexander Nørgård Alsing, None; Anders Kruse, None; Sigridur Olga Magnusdottir, None; Bent Honoré, None; Henrik Vorum, None
  • Footnotes
    Support  This study was supported by A. P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal, Svend Andersen Foundation, Bagger-Sørensen Foundation, North Denmark Region, Hertha Christensen Foundation, Heinrich Kopps Foundation,
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 587. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Lasse Joergensen Cehofski, Alexander Nørgård Alsing, Anders Kruse, Sigridur Olga Magnusdottir, Bent Honoré, Henrik Vorum; Retinal proteome changes following experimental branch retinal vein occlusion and intervention with intravitreal dexamethasone implants. Invest. Ophthalmol. Vis. Sci. 2017;58(8):587.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal proteome changes following treatment with intravitreal dexamethasone implants remain largely unstudied. In an experimental model of branch retinal vein occlusion (BRVO) we studied large-scale retinal protein changes resulting from treatment with Ozurdex implants.

Methods : In five Danish Landrace pigs experimental BRVO was induced in both eyes by applying argon laser onto a vein in the inferior retina (permission 2016-15-0201-00971). Within 30 minutes after BRVO had been induced, a dexamethasone implant (Ozurdex, purchased from Allergan) was injected into the right eye of each animal. A similar injection without any implant was made in the left eyes that served as controls. BRVO was confirmed by fluorescein angiography. Fifteen days after BRVO the eyes were enucleated and the retinas were excised for proteomic analysis. The proteins were digested with trypsin and fractionated using a pH fractionation kit. The peptides were labeled with a tandem mass tag TMT10plex kit and analyzed with liquid chromatography mass spectrometry. Raw data files were searched against the SwissProt database using MaxQuant software. Protein filtration and statistical analysis by paired t-test were performed in Perseus. GeneCodis3 was used for bioinformatic analysis.

Results : After filtering, 3718 proteins were identified in the retinas. In retinas treated with intravitreal dexamethasone implants 40 proteins were significantly upregulated (p < 0.05) and 54 proteins were significantly downregulated (p < 0.05). Ozurdex increased the content of proteins involved in mRNA processing, RNA splicing and ATP binding. Mitochondrial proteins were upregulated following Ozurdex intervention. Ozurdex treatment resulted in a downregulation of proteins that were components of the cytosol, plasma membrane and the nucleus. Downregulated biological processes included growth factor binding, integrin binding and endothelial development. Downregulated KEGG pathways included cytokine-cytokine receptor interaction and cell adhesion.

Conclusions : The data obtained provided new insights into large-scale protein changes resulting from Ozurdex treatment in an experimental model of BRVO. The data indicated that Ozurdex exerts its beneficial effect on the retina by inhibiting growth factor binding, cytokine signaling, integrin signaling and cell adhesion.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×